Daily Sunscreen Cut Skin Ageing 24% — What Korea’s Prevention Model Offers UK Skin Pros

Daily broad-spectrum sunscreen produced 24% less skin ageing over four and a half years than discretionary use, according to a randomised controlled trial of 903 adults. That figure, cited at the seventh PharmaResearch Global Symposium in South Korea, is the hardest evidence behind what Korean clinicians call a shift from "rejuvenation" to "pre-juvenation" — and it frames the most transferable lesson for UK skin professionals.

What did the symposium actually say?

Dr Michael Kim, chief medical officer and executive managing director of medical strategy at PharmaResearch, described the direction of travel in aesthetics. "We're moving towards an age where we're looking more at skin longevity," he said. "It's not just about treating the signs of ageing or symptoms we see, but moving into prevention."

Kim framed skin longevity as a combination of professional intervention, topical support and lifestyle factors. "We also have to treat the skin barrier, which is on the outside," he said, adding diet, exercise, pollution and UV exposure to the list of variables. The event's commercial focus was regenerative aesthetics and injectable polynucleotides (fragments of DNA used as injectable regenerative agents), but the wider message concerned preserving skin function and resilience rather than correcting visible damage.

A caveat follows every promise, and this one is instructive. Kim drew an explicit line between early engagement with facials and skincare advice and early use of injectable procedures. "In Korea, it's very commonplace to start earlier rather than later," he said of first visits to a doctor, skincare specialist or therapist — not of younger patients receiving medical intervention. UK readers should not read the Korean model as a licence to push advanced treatments down the age range.

How big is the Korean skin market, really?

The scale is measurable. South Korea's Ministry of Health and Welfare recorded 2.01 million overseas patients in 2025, up from 1.17 million in 2024. Dermatology accounted for approximately 1.31 million recorded specialty visits, with Seoul attracting the majority. Those figures include medical and aesthetic services beyond the scope of beauty therapy, so they overstate the beauty-therapy market — but they document genuine international demand for Korean skin expertise.

One visible example is Unli Guide — reported as Unni Guide — a Seoul beauty and aesthetics concierge service for international visitors. It offers initial consultation, matching of clients to clinics by concern, preference and budget, appointment booking and interpretation support. The transferable principle for UK salons is guidance: clients frequently need help navigating an overwhelming market more than they need additional treatments.

What does the sunscreen evidence support — and where does it stop?

The 903-participant trial gives therapists grounds to position SPF as a year-round skin-health measure rather than a seasonal extra. Adherence belongs in every consultation, particularly where a client is already paying for pigmentation or photodamage treatment.

The cultural picture is less tidy. A study of 1,173 dermatology patients across 11 Korean hospitals found photoprotection knowledge and behaviour varied between demographic groups, with some practices remaining inadequate. Imitating an idealised version of Korean skincare is therefore not the lesson; recommending textures clients will actually use, explaining application and checking adherence at follow-up appointments is.

Barrier care follows the same logic. A strong plan may involve removing products rather than adding them — gentle cleansing, suitable moisturisation and fewer irritants beat a crowded routine of fashionable actives. That discipline matters as Korean-originating ingredients such as PDRN (polydeoxyribonucleotide, a salmon-DNA-derived regenerative ingredient), exosomes and spicule-based products attract UK interest; therapists should assess the finished formulation, intended use and supporting evidence rather than the ingredient's popularity.

When does prevention become over-treatment?

The risks are documented, not hypothetical. The American Academy of Dermatology recommends only gentle cleansing, fragrance-free moisturiser and broad-spectrum SPF 30 or higher for tweens, and advises against retinoids, exfoliating acids and vitamin C absent a specific clinical reason.

A 2026 survey of dermatologists sharpens that warning:

• 91.6% expressed concern about multi-step routines among children and adolescents;
• 88.1% regularly encountered skincare-related problems including irritant eczema, perioral dermatitis, allergic contact dermatitis and acne associated with cosmetic products;
• retinoids, acids and fragrance were among the commonly implicated product features.

Research on Korean adolescents links body image, media influence and self-esteem to perceived need for cosmetic procedures, which is why early beauty engagement cannot be treated as automatically harmless. Kim conceded the point himself. "There's always the extreme, and we need to avoid the extremes on that spectrum," he said.

What can UK professionals actually adopt?

The source sets out seven transferable principles:

• Position professional skincare as ongoing education, with periodic reviews rather than crisis visits;
• Make SPF and barrier support the foundation that advanced treatments cannot replace;
• Prioritise consistency over novelty;
• Treat the consultation itself as a paid area of expertise — product editing and routine planning carry value;
• Introduce changes in stages to identify irritants and avoid treatment stacking;
• Measure what matters, documenting comfort, function and confidence alongside repeatable photography;
• Keep prevention ethically proportionate and age-appropriate.

Monitoring has its own limit, which Kim acknowledged: "The trend has already moved to skin quality, but the assessment has not followed." Changes in hydration, elasticity, redness, pigmentation and pores remain difficult to capture through standard photography, so consistent lighting and written records matter more than expensive diagnostic kit.

Disclosure: Ellen Cummings of Professional Beauty travelled to South Korea as a guest of PharmaResearch and Rejuran, with flights, accommodation and itinerary provided. Read in that light, the strongest defensible conclusion is narrow but useful: a prevention-first practice should leave clients needing less corrective intervention, not feeling that healthy, functioning skin is inadequate.